Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R. J. Mullin
Evaluation of Lapatinib and Topotecan Combination Therapy: Tissue Culture, Murine Xenograft, and Phase I Clinical Trial Data
Clinical Cancer Research
Cancer Research
Oncology
Related publications
A Phase I Trial of Combination Trastuzumab, Lapatinib, and Bevacizumab in Patients With Advanced Cancer
Investigational New Drugs
Oncology
Pharmacology
Phase II Trial of Lapatinib and Topotecan (LapTop) in Patients With Platinum-Refractory/Resistant Ovarian and Primary Peritoneal Carcinoma
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Phase I Trial of Weekly Topotecan and Gemcitabine in Patients With Solid Tumors
American Journal of Clinical Oncology: Cancer Clinical Trials
Cancer Research
Oncology
Gene Therapy for Pain: Results of a Phase I Clinical Trial
Annals of Neurology
Neurology
Evaluation of Wearable Digital Devices in a Phase I Clinical Trial
Clinical and Translational Science
Genetics
Molecular Biology
Pharmacology
Biochemistry
Neuroscience
Medicine
Toxicology
Pharmaceutics
A Phase I and Pharmacokinetic Study of Intraperitoneal Topotecan
British Journal of Cancer
Cancer Research
Oncology
Preclinical and Phase I Clinical Studies of KW-2450, a Dual IGF-1R/IR Tyrosine Kinase Inhibitor, in Combination With Lapatinib and Letrozole
Therapeutic Advances in Medical Oncology
Oncology
Escalation Strategies for Combination Therapy Phase I Trials
Pharmaceutical Statistics
Statistics
Probability
Pharmacology
A Phase I Clinical Trial and Independent Patient-Derived Xenograft Study of Combined Targeted Treatment With Dacomitinib and Figitumumab in Advanced Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
